Studies have shown that leukemia-associated missense mutations impair the enzymatic activity of TET2 and lead to a decrease in the genomic level of 5-hydroxymethyl-cytosine, which disrupts normal hematopoiesis and may accelerate leukemia formation (32). Here, TET2 is linked to leukemia.